Symptoms of nicotine toxicity in subjects achieving high cotinine levels during nicotine replacement therapy

Nicotine and Tobacco Research

Volumn 16, Issue 9, 2014, Pages

  Tonstad, Serena ^a   Gustavsson, Gunnar ^b   Kruse, Elisabeth ^c   Walmsley, James M ^d   Westin, Åke ^e  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b Pharmaceutical R and D   (Sweden)

^c Global Medical Affairs and Clinical Research   (Sweden)

^d JOHNSON AND JOHNSON   (United States)

^e Global Biostatistics McNeil AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; NICOTINE; NICOTINE GUM; NICOTINE PATCH; NOSE SPRAY;

ARTICLE; CHEWABLE TABLET; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DRUG BLOOD LEVEL; DRUG INDUCED HEADACHE; DRUG INTOXICATION; DRUG OVERDOSE; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; INCIDENCE; INHALER; MAJOR CLINICAL STUDY; MALE; NAUSEA; NICOTINE REPLACEMENT THERAPY; ORAL SPRAY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRANSDERMAL PATCH; VOMITING; BLOOD; DOUBLE BLIND PROCEDURE; INHALATIONAL DRUG ADMINISTRATION; INTRADERMAL DRUG ADMINISTRATION; META ANALYSIS; PROCEDURES; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INHALATION; COTININE; DOUBLE-BLIND METHOD; HUMANS; NICOTINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER;

EID: 84906046844     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntu076     Document Type: Article

References (43)

1. Batra, A., Klinger, K., Landfeldt, B., Friederich, H.M., Westin, Å., & Danielsson, T. (2005). Smoking reduction treatment with a 4 mg nicotine gum: A double-blind, randomized, placebo-controlled study. Clinical Pharmacology & Therapeutics, 78, 689-696. doi:10.1016/j.clpt.2005.08.019
2. Benowitz, N.L. (1988). Toxicity of nicotine: Implications with regard to nicotine replacement therapy. Progress in Clinical and Biological Research, 261, 187-217.
3. Benowitz, N.L., Hukkanen, J., & Jacob, P., 3rd. (2009). Nicotine chemistry, metabolism, kinetics and biomarkers. Handbook of Experimental Pharmacology, 192, 29-60. doi:10.1007/978-3-540-69248-5_2
4. Bohadana, A., Nilsson, F., Rasmussen, T., & Martinet Y. (2000). Nicotine inhaler and nicotine patch as combination for smoking cessation-a randomized, double-blind, placebo-controlled trial. Archives of Internal Medicine, 160, 3128-3134. doi:10.1001/archinte.160.20.3128
5. Bohadana, A.B., Nilsson, F., Westin, A., Martinet, N., & Martinet, Y. (2006). Smoking cessation-but not smoking reduction-improves the annual decline in FEV1 in occupationally exposed workers. Respiratory Medicine, 100, 1423-1430. doi:10.1016/j.rmed.2005.11.005
6. Bolliger, C.T., Zellweger, J.-P., Danielsson, T., van Biljon, X., Robidou, A., Westin, Å., Säwe, U. (2000). Smoking reduction with oral nicotine inhalers: Double blind, randomised clinical trial of efficacy and safety. British Medical Journal, 321, 329-333. doi:10.1136/bmj.321.7257.329
7. Carpenter, M.J., Jardin, B.F.,Burris, J.L., Mathew, A.R., Schnoll, R.A., Rigotti, N.A., & Cummings, K.M. (2013). Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: A review of the literature. Drugs, 73, 407-426. doi:10.1007/s40265-013-0038-y
8. Dale, L.C., Hurt, R.D., Offord, K.P., Lawson, G.M., Croghan, I.T., & Schroeder, D.R. (1995). High-dose nicotine patch therapy. Journal of the American Medical Association, 274, 1353-1358. doi:10.1001/jama.1995.03530170033028
9. Danielsson, T., Rössner, S., & Westin, Å. (1999). Open randomised trial of intermittent very low energy diet together with nicotine gum for stopping smoking in women who gained weight in previous attempts to quit. British Medical Journal, 319, 490-494. doi:10.1136/bmj.319.7208.490
10. Fagerström, K.O., & Hughes, J.R. (2002). Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: A review. Nicotine & Tobacco Research, 4 (Suppl. 2), S73-S79. doi:10.1080/1462220021000032753
11. Fredrickson, P.A., Hurt, R.D., Lee, G.M., Wingender, L., Croghan, I.T., Lauger, G., Offord, K.P. (1995). High dose transdermal nicotine therapy for heavy smokers: Safety, tolerability and measurement of nicotine and cotinine evels. Psychopharmacology, 122, 215-222. doi:10.1007/BF02246542
12. Glover, E.D., Glover, P.N., Franzon, M., Sullivan, C.R., Cerullo, C.C., Howell, R.M., Hobbs, G.R. (2002). A comparison of a nicotine sublingual tablet and placebo for smoking cessation. Nicotine & Tobacco Research, 4, 441- 450. doi:10.1080/1462220021000018443
13. Gourlay, S.G., Benowitz, N.L., Forbes, A., & McNeil, J.J. (1997). Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatment. European Journal of Clinical Pharmacology, 51, 407-414. doi:10.1007/s002280050222
14. Haustein, K.-O., Krause, J., Haustein, H., Rasmussen, T., & Cort, N. (2003). Comparison of the effects of combined nicotine replacement therapy vs. cigarette smoking in males. Nicotine & Tobacco Research, 5, 195-203. doi:10.1080/146222003100073676
15. Haustein, K.-O., Krause, J., Haustein, H., Rasmussen, T., & Cort, N. (2004). Changes in hemorheological and biochemical parameters following short- and long-term smoking cessation induced by nicotine replacement therapy (NRT). International Journal of Clinical Pharmacology and Therapeutics, 42, 83-92.
16. Hjalmarson, A., Franzon, M., Westin, Å., & Wiklund, O. (1994). Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blind study. Archives of Internal Medicine, 154, 2567-2572. doi:10.1001/ archinte.1994.00420220059007
17. Hjalmarson, A., Nilsson, F., Sjostrom, L., & Wiklund, O. (1997). The nicotine inhaler in smoking cessation. Archives of Internal Medicine, 157, 1721-1728. doi:10.1001/ archinte.1997.00440360143016
18. Homsy, W., Yan, K., Houle, J.-M., Besner, J.-G., Gossard, D., Pierce, C.H., & Caille, G. (1997). Plasma levels of nicotine and safety of smokers wearing transdermal delivery systems during multiple simultaneous intake of nicotine and during exercise. Journal of Clinical Pharmacology, 37, 728-736. doi:10.1002/j.1552-4604.1997.tb04360.x
19. Johnstone, E., Benowitz, N., Cargill, A., Jacob, R., Hinks, L., Day, I., Murphy, M., & Walton, R. (2006). Determinants of the rate of nicotine metabolism and effects on smoking behaviour. Clinical Pharmacology & Therapeutics, 80, 319- 330. doi:10.1016/j.clpt.2006.06.011
20. Kornitzer, M., Boutsen, M., Dramaix, M., Thijs, J., & Gustavsson, G. (1995). Combined use of nicotine patch and gum in smoking cessation: A placebo-controlled clinical trial. Preventive Medicine, 24, 41-47. doi:10.1006/ pmed.1995.1006
21. Kralikova, E., Kozak, J.T., Rasmussen, T., Gustavsson, G., & Le Houezec, J. (2009). Smoking cessation or reduction with nicotine replacement therapy: A placebo-controlled, double- blind trial with nicotine gum and inhaler. BMC Public Health, 9, 433. doi:10.1186/1471-2458-9-433
22. Leischow, S.J., Nilsson, F., Franzon, M., Hill, A., Otte, P., & Merikle, E.P. (1996). Efficacy of the nicotine inhaler as an adjunct to smoking cessation. American Journal of Health Behaviour, 20, 364-371.
23. Lindson, N., & Aveyard, P. (2011). An updated meta-analysis of nicotine preloading for smoking cessation: Investigating mediators of the effect. Psychopharmacology, 214, 579-92. doi:10.1007/s00213-010-2069-3
24. Murray, R.P., Nides, M.A., Istvan, J.A., & Daniels, K. (1998). Levels of cotinine associated with long-term nicotine polacrilex use in a clinical trial. Addictive Behavior, 23, 529-535. doi:10.1016/S0306-4603(97)00073-7
25. Paoletti, P., Fornai, E., Maggiorelli, F., Puntoni, R., Viegi, G., Carozzi, L., Giuntini, C. (1996). Importance of baseline cotinine plasma values in smoking cessation: Results from a double-blind study with nicotine patch. European Respiratory Journal, 9, 643-651. doi:10.1183/09031936. 96.09040643
26. Puska, P., Korhonen, H.J., Vartiainen, E., Urjanheimo, E.L., Gustavsson, G., & Westin, Å. (1995). Combined use of nicotine patch and gum compared with gum alone in smoking cessation: A clinical trial in North Karelia. Tobacco Control, 4, 231-235. doi:10.1136/tc.4.3.231
27. Rennard, S.I., Glover, E., Leischow, S., Daughton, D.M., Glover, P., Muramoto, M., Westin, Å. (2006). Efficacy of nicotine inhaler in smoking reduction: A double-blind, randomized trial. Nicotine & Tobacco Research, 8, 555-564. doi:10.1080/14622200600789916
28. Russell, M.A. H. (1988). Nicotine replacement: The role of blood nicotine levels, their rate of change, and nicotine tolerance. In O.F. Pomerlean & C.S. Pomerleau (Eds.), Progress in clinical and biological research, nicotine replacement: A critical evaluation (Vol. 261, pp. 63-94). New York: Alan R. Liss Inc.
29. Sachs, D.P. L., Sawe, U., & Leischow, S.J. (1993). Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Archives of Internal Medicine, 153, 1881-1890. doi:10.1001/ archinte.1993.00410160041003
30. Schneider, N.G., Olmstead, R., Nilsson, F., Vaghaiwalla Mody, F., Franzon, M., & Doan, K. (1996). Efficacy of a nicotine inhaler in smoking cessation: A double-blind, placebo-controlled trial. Addiction, 91, 1293-1306. doi:10.1080/09652149639529
31. Schneider, N.G., Olmstead, R., Vaghaiwalla Mody, F., Doan, K., Franzon, M., Jarvik, M.E., & Steinberg, C. (1995). Efficacy of a nicotine nasal spray in smoking cessation: A placebo-controlled, double-blind trial. Addiction, 90, 1671-1682. doi:10.1080/09652149541013
32. Stapleton, J.A., Russell, M.A. H., Feyerabend, C., Wiseman, S.M., Gustavsson, G., Sawe, U., & Wiseman, D. (1995). Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction, 90, 31-42. doi:10.1080/09652149542670
33. Stapleton, J.A., & Sutherland, G. (2011). Treating heavy smokers in primary care with the nicotine nasal spray: Randomized placebo-controlled trial. Addiction, 106, 824- 832. doi:10.1111/j.1360-0443.2010.03274.x
34. Stead, L.F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster T. (2012). Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews, 11, CD000146. doi:10.1002/14651858. CD000146.pub4
35. Sutherland, G., Stapleton, J.A., Russell, M.A., Jarvis, M.J., Hajek, P., Belcher, M., & Feyerabend, C. (1992). Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet, 340, 324-329. doi:10.1016/0140-6736(92)91403-U
36. Tønnesen, P., Lauri, H., Perfekt, R., Mann, K., & Batra, A. (2012). Efficacy of a nicotine mouth spray in smoking cessation: A randomised, double-blind trial. European Respiratory Journal, 40, 548-554. doi:10.1183/09031936.00155811
37. Tönnesen, P., Norregaard, J., Mikkelson, K., Jörgensen, S., & Nilsson, F. (1993). A double-blind trial of a nicotine inhaler for smoking cessation. JAMA: The Journal of the American Medical Association, 269, 1268-1271. doi:10.1001/ jama.1993.03500100066029
38. Tönnesen, P., Nörregard, J., Simonsen, K., & Säwe, U. (1991). A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. New England Journal of Medicine, 325, 311-315. doi:10.1056/NEJM199108013250503
39. Tönnesen, P., Paoletti, P., Gustavsson, G., Russell, M.A., Saracci, R., Gulsvik, A., Sawe, U. (1999). Higher dosage nicotine patches increase one-year smoking cessation rates: Results from the European CEASE trial. European Respiratory Journal, 13, 238-246. doi:10.1034/j.1399-3003.1999.13b04.x
40. Tønnesen, P., Pisinger, C., Hvidberg, S., Wennike, P., Bremann, L., Westin, Å., Nilsson, F. (2005). Effects of smoking cessation and reduction in asthmatics. Nicotine & Tobacco Research, 7, 139-148. doi:10.1080/14622200412331328411
41. Wallström, M., Nilsson, F., & Hirsch, J.M. (2000). A randomized, double-blind, placebo-controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation. Addiction, 95, 1161-1171. doi:10.1046/j.1360-0443.2000.95811613.x
42. Wennike, P., Danielsson, T., Landfeldt, B., Westin, Å., & Tönnesen, P. (2003). Smoking reduction promotes smoking cessation. Results from a double blind, randomised, placebo-controlled trial of nicotine gum with 2-year follow-up. Addiction, 98, 1395-1402. doi:10.1046/j.1360-0443.2003.00489.x
43. Woolf, K.J., Zabad, M.N., Post, J.M., McNitt, S., Williams, G.C., & Bisognano, J.D. (2012). Effect of nicotine replacement therapy on cardiovascular outcomes after acute coronary syndromes. American Journal of Cardiology, 110, 968-970. doi:10.1016/j.amjcard.2012.05.028